Introduction
============

*Stenotrophomonas maltophilia* is a Gram-negative, non-fermentative bacterium, which is usually associated with the rhizosphere but can cause opportunistic infections of the respiratory tract in immunocompromised patients. In recent years, *S. maltophilia* has been frequently isolated from cystic fibrosis patient. As a nosocomial pathogen, it can also cause numerous infections in other organs and tissues, including bacteremia, endocarditis, pneumonia, peritonitis, cellulitis, and meningitis ([@B2]; [@B27]; [@B61]; [@B34]; [@B26]; [@B5]). Treatment is often difficult because the microorganism is intrinsically resistant against many common antibiotics including β-lactams ([@B22]; [@B18]; [@B69]; [@B17]). The intrinsic resistance of *S. maltophilia* K279a (SMK279a) against β-lactam antibiotics is primarily due to the function of two β-lactam resistance genes, *bla*~L1~ (*smlt2667*) and *bla*~L2~ (*smlt3722*), ([@B70]; [@B78], [@B79]). The product of *bla*~L1~ is an Ambler class B Zn^+^-dependent metalloenzyme, and the product of *bla*~L2~ is an Ambler class A serine active site β-lactamase. Both enzymes are responsible for inactivation of a wide range of different β-lactam antibiotics ([@B78], [@B79]; [@B3]).

Expression of *bla*~L1~ and *bla*~L2~, which is controlled by the activities of several proteins including AmpG, NagZ, AmpD, and the transcriptional regulator AmpR ([@B19]; [@B10]; [@B31]; [@B41]; [@B63]), has been suggested to be induced by β-lactam antibiotics. Furthermore, the expression of β-lactam resistance genes is linked to cell wall biosynthesis, a complex dynamic process affected by multiple cellular processes such as growth phase, division cycle, quorum sensing, and cell stress ([@B77]; [@B83]). In addition to its autoregulation of transcription, AmpR regulates the induction of chromosomal β-lactamases in Gram-negative bacteria ([@B13]). A homologous *ampR-bla*~L2~ module with a similar induction mechanism has been identified earlier in *S. maltophilia* ([@B51]). In this bacterium*, ampR* (*smlt3723*) is physically linked to *bla*~L2~, and it is assumed that AmpR can also regulate the expression of the unlinked *bla*~L1~ gene ([@B63]). In the absence of an inducer, AmpR maintains its inactive conformational state as a result of binding to effector molecules, i.e., UDP-MurNAc-oligopeptides. However, exposure of the bacteria to β-lactam antibiotics increases cytosolic accumulation of anhydro-MurNAc-oligopeptides, a cell wall degradation product, which can displace the AmpR-associated UDP-MurNAc-oligopeptides. This leads to a conformational change of AmpR and subsequent activation of *bla*~L1~ and *bla*~L2~ transcription ([@B25]; [@B42]; [@B13]).

While it is well known that the genetic background determines the ability of a bacterial strain to overcome antibiotic stress, bacteria have developed additional mechanisms to successfully overcome antibiotic treatment. These mechanisms may include smaller genetic variations such as single nucleotide polymorphisms (SNPs) and non-genetic variations. Within this context, phase variations can also be the cause of antibiotic resistance and/or phenotype switching. They occur at a rate of 1:10,000 in a population and can be the result of different events ([@B38]; [@B76]; and references herein).

Non-genetic variations that exist within an isogenic population contribute to the survival and fitness of the population ([@B1]; [@B33]). In a clonal population, cell-to-cell variation may result in a measurable phenotype termed phenotypic heterogeneity ([@B44]; [@B53]). Phenotypic heterogeneity via heterogeneous gene expression benefits the population through division of labor and bet-hedging in a homogeneous environment as represented by laboratory culture conditions. This has been demonstrated for a number of model organisms such as *Salmonella enterica* serovar Typhimurium, *Vibrio harveyi, Bacillus subtilis*, *Sinorhizobium fredii*, and others ([@B8]; [@B23]; [@B60]; [@B32]; [@B80]). Therefore, phenotypic heterogeneity is a way of multicellularity in bacterial populations to enhance the ability to adapt to changing environments ([@B73]; [@B20]) and, consequently needs to be better understood to optimize antibiotic treatment strategies.

It has been shown that some bacteria can survive an antibiotic treatment by stochastically entering a dormant persister state during vegetative growth. The persister cells form transiently antibiotic tolerant subpopulations susceptible to re-introduction of the antibiotic stress, indicating that non-genetic mechanisms are involved in this process ([@B49], [@B50]). Much research has been focused on the exploration of the molecular keys linked to the persister phenomenon. For a more detailed insight into this topic, we refer to the excellent reviews given in references ([@B50]; [@B37]; [@B55]). The persister phenotype depends on various factors such as the level of signaling nucleotide (p)ppGpp, and various metabolic activities ([@B54]; [@B6]). Thereby it is well accepted that toxin--antitoxin (TA) systems play a key role in the regulatory network of persisters. These systems consist of a 'toxin', which is normally a stable protein that interferes with vital cellular functions and a cognate 'antitoxin', an unstable protein or RNA molecule, which regulates the toxin level. The most prominent example for a TA system controlling persistence is the *Escherichia coli hipAB* TA system. However, additional systems have been described and ranked in the order of their importance ([@B45]; [@B49]; [@B81]).

Here we report phenotypic heterogeneity in SMK279a upon exposure to β-lactam antibiotics. SMK279a was isolated from a blood sample of a hospitalized patient and has a genome size of 4,851,126 bp ([@B18]). In the presence of ampicillin, SMK279a cells showed heterogeneity in colony and cell morphology, which goes along with colony-specific patterns of differentially expressed genes, including expression of the β-lactam resistance genes *bla~L1~ and bla~L2~*. As demonstrated with reporter gene fusions, *bla~L1~ and bla~L2~* are subject to differential regulation even at the single cell level. Together with genome-wide sequences of cells from the different colony morphotypes, our data show that phenotypic heterogeneity in *S. maltophilia* K279a is a result of non-genetic variations in individual cells within isogenic populations.

Materals And Methods
====================

Bacterial Strains, Plasmids, and Growth Conditions
--------------------------------------------------

All strains and plasmids used in the present study are described in **Table [1](#T1){ref-type="table"}**. *S. maltophilia* and *E. coli* strains were routinely grown either in LB medium (10 g/l tryptone, 5 g/l yeast extract and 5 g/l NaCl) or on LB agar plates at 30 or 37°C. Ampicillin (100 μg/ml), gentamicin (10 μg/ml), kanamycin (25 μg/ml), chloramphenicol (60 μg/ml), norfloxacin (5 μg/ml), or tetracycline (50 μg/ml) was added to the media as required. For analyses of phenotypic colony heterogeneity, SMK279a was spread on LB agar plates without or with ampicillin (100 μg/ml) and incubated at 37°C for 48 h. Pre-cultures were grown in 5 ml test tubes at 37°C. For analysis of single cell expression, cultures were grown for 12 to 15 generations in LB broth supplemented with gentamicin (50 μg/ml) and without β-lactam inducer. The Minimal Inhibitory Concentration (MIC) for ampicillin was analyzed using the microdilution technique and found to be at a level of 254 μg/ml.

###### 

Bacterial strains and plasmids used in this work.

  Strain or construct                                    Description                                                                                                                                Reference
  ------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------
  ***Escherichia coli* strains**                                                                                                                                                                    
  HB101                                                  F^-^, *hsd*S20(r~B~^-^m~B~^-^), *rec*A13, *ara*14, *pro*A2, *lac*Y1, *gal*K2,*rps*L20 (Sm^R^) *xyl*-5, *mtl*-1, *sup*E44, λ^-^,            [@B28]
  SY327                                                  Δ(*lac pro*) *argE*(*Am*) *recA56 rif ^R^ nalA*λ *pir*                                                                                     [@B58]
  DH5α                                                   F^-^ Φ80*lacZ*ΔM15 Δ(*lacZYA-argF*) U169 *recA1 endA1 hsdR17*(r~K~^-^ m~K~^+^) *phoA supE44 thi-1 gyrA96 relA1*λ^-^                        [@B36]
  ***Stenotrophomonas maltophilia* strains**                                                                                                                                                        
  SMK279a                                                Clinical isolate from the blood of a cancer patient                                                                                        [@B11]
  SMK279aΔ*smlt1134*                                     SMK279a lacking the *smlt1134* gene coding for a putative DNA transport competence protein                                                 This study
  SMK279aΔ*smlt2851*Δ *smlt2852*                         SMK279a lacking the *smlt2851* and *smlt2852* genes coding for putative transmembrane eﬄux proteins                                        This study
  SMK279aΔ*smlt3723*                                     SMK279a lacking the *ampR* (*smlt3723*) gene; a putative HTH and LysR family transcriptional regulator                                     This study
  SMK279aΔ*smlt0387*                                     SMK279a carrying a deletion in *smlt0387*                                                                                                  This study
  SMK279a EM2                                            SMK279a carrying pBBR1MCS-5::P*bla*~L2~::*rfp*                                                                                             This study
  SMK279a EM3                                            SMK279a carrying pBBR1MCS-5::P*bla*~L1~::*rfp*                                                                                             This study
  SMK279a EM4                                            SMK279a carrying pBBR1MCS-5::P~less~::*rfp*                                                                                                This study
  SMK279a EM5                                            SMK279a carrying pBBR1MCS-5::P*bla*~L2~::*cfp*                                                                                             This study
  SMK279a EM6                                            SMK279a carrying pBBR1MCS-5::P*bla*~L2~::*yfp*                                                                                             This study
  SMK279a EM7                                            SMK279a carrying pBBR1MCS-5::P*bla*~L2~s::*rfp*                                                                                            This study
  SMK279a EM8                                            SMK279a carrying pBBR1MCS-5::P*bla*~L2~::*rfp::smlt1134*                                                                                   This study
  SMK279a EM9                                            SMK279a carrying pBBR1MCS-5::P*bla*~L2~::*rfp:: smlt2851*::*smlt2852*                                                                      This study
  CF148                                                  Clinical isolate from the respiratory tract of a cystic fibrosis patient                                                                   Jörg Steinmann (Universitätsklinikum Essen)
  DSM-50170                                              Reference strain from the oropharyngeal region of a patient with cancer                                                                    Leibniz institute DSMZ
  **Plasmids**                                                                                                                                                                                      
  pRK2013                                                Kan^R^; RK2-derived helper plasmid carrying the *tra* and *mob* genes for mobilization of plasmids containing *oriT*                       [@B28]
  pBBR1MCS-5                                             Broad host range vector, low copy, Gm^r^                                                                                                   [@B46]
  pBBR1MCS-5::*rfp*                                      pBBR1MCS-5 carrying the *rfp* gene in the MCS                                                                                              This study
  pBBR1MCS-5::P*bla*~L1~::*rfp*                          P*bla*~L2~::*rfp* reporter fusion in pBBR1MCS-5                                                                                            This study
  pBBR1MCS-5::P*bla*~L2~::*rfp*                          P*bla*~L1~::*rfp* reporter fusion in pBBR1MCS-5                                                                                            This study
  pBBR1MCS-5::P*bla*~L2~::*yfp*                          P*bla*~L2~::*yfp* reporter fusion in pBBR1MCS-5                                                                                            This study
  pBBR1MCS-5::P*bla*~L2~::*cfp*                          P*bla*~L2~::*cfp* reporter fusion in pBBR1MCS-5                                                                                            This study
  pBBR1MCS-5::P~less~::*rfp*                             Promoterless *rfp* reporter fusion in pBBR1MCS-5                                                                                           This study
  pBBR1MCS-5::P*bla*~L2~s::*rfp*                         P*bla*~L2~s::*rfp* reporter fusion constructed with the *ampR-bla*~L2~ intergenic region in pBBR1MCS-5                                     This study
  pBBR1MCS-5:: P*bla*~L2~::*rfp::smlt1134*               *smlt1134* gene under its native promoter cloned into the pBBR1MCS-5::P*bla*~L2~::*rfp* reporter fusion                                    This study
  pBBR1MCS-5::P*bla*~L2~::*rfp:: smlt2851*::*smlt2852*   Putative operon of *smlt2851* and *smlt2852* under its native promoter cloned into the pBBR1MCS-5::P*bla*~L2~::*rfp* reporter fusion       This study
  pGPI-SceI-XCm                                          Cm^R^, Tp^R^; mobilizable suicide vector; carries the R6Kγ origin of replication, the I-SceI recognition site and a *xylE* reporter gene   [@B35]
  pDAI-SceI-SacB                                         Tet^R^; mobilizable broad host range plasmid; carries the gene for the I-SceI homing endonuclease and the *sacB* gene                      [@B29]; [@B35]
  pUDK011                                                pGPI-SceI-XCm with a 705-bp *Sph*I/*Kpn*I insert of SMK279a containing the flanking region upstream of *smlt1134*                          This study
  pUDK012                                                pUDK011with a 741-bp *Kpn*I/*Xba*I insert of SMK279a containing the flanking region downstream of *smlt1134*                               This study
  pUDK014                                                pGPI-SceI-XCm with a 779-bp *Not*I/*Kpn*I insert of SMK279a containing the flanking region upstream of *smlt2852*                          This study
  pUDK015                                                pUDK014 with a 776-bp *Kpn*I/*Xba*I insert of SMK279a containing the flanking region downstream of *smlt2851*                              This study
  pUDK017                                                pGPI-SceI-XCm with a 761-bp *Not*I/*Kpn*I insert of SMK279a containing the flanking region upstream of *smlt3723*                          This study
  pUDK018                                                pUDK017 with a 660-bp *Kpn*I/*Xba*I insert of SMK279a containing the flanking region downstream of *smlt3723*                              This study
                                                                                                                                                                                                    

Scanning and Fluorescence Microscopy
------------------------------------

Scanning electron microscopy (SEM) was performed as previously published ([@B47]). Therefore, bacterial cells were grown overnight in 5 ml LB broth or on LB agar plates for 48 h. The cell suspension was centrifuged at 13,000 rpm for 2 min. The pellets or the colonies were resuspended in 500 μl sterile PBS-buffer, fixed in paraformaldehyde (1%) and glutaraldehyde (0.25%) and dehydrated gradually after successive immersions in ethanol solutions of increasing concentrations (30, 50, 70, 90, and 96%). Each rinsing and dehydrating step lasted 10 min. Finally, cells were dehydrated overnight in absolute ethanol (99.6%). The drying step was completed by drying pelletized cells at the critical point with the Balzers CPD 030 Critical Point Dryer. After coating samples with gold using an SCD 050 sputter coater (Bal-Tec), scanning electron micrographs were taken with a Leo 1525 (Zeiss, Germany).

Single cell analyses were evaluated as previously described ([@B32]). The phase-contrast and fluorescence images were recorded using a Zeiss AxioCam microscope with an MRm camera mounted on the fluorescence microscope (Zeiss Axio Imager.M2; Carl Zeiss AG, Oberkochen, Germany). For fluorescence imaging, the microscope was equipped with filter BP546/12 (red), the emission filter 605/75 (red), and a Zeiss Illuminator HXP 120 C. Phase-contrast and fluorescence images were obtained from the same area and matched using the Axio-Vision software (release 4.8). The fluorescence phenotypes of single cells were recorded by evaluating, in general, a minimum of 400 cells per biological sample. For each treatment, at least three independent samples were analyzed by visually inspecting the obtained images.

Molecular Cloning and Generation of SMK279a Mutants
---------------------------------------------------

For construction of the reporter gene fusions, the genes *rfp* (DsRed2; [@B12]), *cfp* (mCerulean; [@B66]) and *yfp* (mVenus; [@B71]) were fused to DNA fragments carrying the promoter of the *bla*~L1~ gene or the promoter and intergenic region of the *bla*~L2~ gene. The DNA fragments containing the promoter region were 318 bp for *bla*~L2~, the intergenic region 180 bp for *bla*~L2~ and 417 bp for *bla*~L1~, and were predicted using PromBase ([@B65]). These cassettes were cloned into the broad host range vector pBBR1MCS-5 ([@B46]). Constructs were verified by DNA sequencing. The recombinant plasmids were transferred to SMK279a by triparental mating, using *E. coli* HB101 carrying the plasmid pRK2013 as a helper strain ([@B28]).

Markerless SMK279a mutants were constructed using the pGPI-SceI/pDAI-SceI-SacB system originally developed for bacteria of the genus *Burkholderia* ([@B29]; [@B9]). The bacterial strains and plasmids of the pGPI-SceI/pDAI-SceI-SacB system were a generous gift from Miguel A. Valvano (Center for Infection and Immunity, Queen's University, Belfast, UK). The mutagenesis method is based on the I-SceI homing endonuclease system, which relies on two independent crossover events to integrate first a deletion plasmid with a I-SceI recognition site into the genome of the recipient and then resolve the co-integrate structure by a second homologous recombination event in the presence of the I-SceI endonuclease provided *in trans* on plasmid pDAI-SceI-SacB. The deletion plasmid was derived from the mobilizable suicide vector pGPI-SceI-XCm and contained upstream and downstream flanking regions of the gene to be deleted. All deletion plasmids were generated and maintained in *E. coli* SY327 ([@B58]), which constitutively expresses the λ *pir* gene product for replication of plasmids containing the R6Kγ origin of replication such as pGPI-SceI-XCm. To construct the deletion plasmid pUDK012 targeting the *smlt1134* gene of SMK279a, the primers KOsmlt1134-1, and KOsmlt1134-2 (**Table [2](#T2){ref-type="table"}**) were used to amplify a 705 bp fragment of the flanking region upstream of *smlt1134*, followed by digestion of the PCR product with *Sph*I/*Kpn*I and cloning into the *Sph*I/*Kpn*I sites of pGPI-SceI-XCm. The resulting plasmid was designated pUDK011. The flanking downstream region of *smlt1134* of 741 bp was obtained by PCR with primer pair KOsmlt1134-3/KOsmlt1134-4. The PCR product was then digested with *Kpn*I/*Xba*I and cloned into the *Kpn*I/*Xba*I sites of pUDK011 to yield pUDK012. For deletion of the genomic region containing the *smlt2852* and *smlt2851* genes, the plasmid pUDK015 was constructed. As a first step, the plasmid pUDK014 was generated by amplification of the flanking upstream region of *smlt2852* with primers KOsmlt2852-1 and KOsmlt2852-2, digestion of the PCR product with *Not*I/*Kpn*I and ligation of the 779 bp insert into the *Not*I/*Kpn*I sites of pGPI-SceI-XCm. The primer pair KOsmlt2851-3/KOsmlt2851-4 was subsequently used to amplify a 776 bp fragment containing the flanking downstream sequences of *smlt2851*, followed by cloning of the *Kpn*I- and *Xba*I-digested PCR product into the *Kpn*I/*Xba*I sites of pUDK014 to yield the deletion plasmid pUDK015.

###### 

Primers used in this study.

  Primer         Sequence \[5′-3′\]
  -------------- -----------------------------------------
  Smlt3722For    CTTAGGTACCCGGATCTGGTGGCTCAGT
  Smlt3722Rev    CGATGAATTCCGAGCATGCGGGTTCTCCTG
  3722rfpFor     CTTAGGTACCCATCGCGCAGTCGTGA
  3722rfpRev     CGTTGAATTCATGCGGGTTCTCCTGG
  Ma2667For      CTTAGGTACCAACCGGCTGACTGCGTTCT
  Ma2667Rev      CGATGAATTCGATCCACGTCCGCTTGAAG
  KOsmlt1134-1   ATATTgcatgcCTCTTCACAGGCTTCGATCAGC*^a^*
  KOsmlt1134-2   CTAGACggtaccCAAGGCACAACGTGTATCTCCC*^b^*
  KOsmlt1134-3   CCCGGATCggtaccGGTGCG*^b^*
  KOsmlt1134-4   CTTCTtctagaTGTTGTAGAGGTTGGACCTGTGG*^c^*
  KOsmlt2852-1   CCTGAgcggccgcCACGTACACCGACAGTTCG*^d^*
  KOsmlt2852-2   TAGACggtaccATGGGCCATGAACGAGGTG*^b^*
  KOsmlt2851-3   CATGCggtaccGCATCGCATTGGTGACCGTC*^b^*
  KOsmlt2851-4   TACCGtctagaGCTTCGATTCCAGCAACTGGG*^c^*
  KOsmlt3723-1   CCTGAgcggccgcTTGGCAAAGCTGTTCAGCTCC*^d^*
  KOsmlt3723-2   TAGACggtaccTTCAGTGGCAGGGTAGGGTG*^b^*
  KOsmlt3723-3   CATGCggtaccGCATGTTCGAGCAGGAACTGG*^b^*
  KOsmlt3723-4   TACCGtctagaGATCGTGATGGTCTCTCACGAC*^c^*
                 

a

Sph

I site is shown in lower case letters.

b

Kpn

I site is shown in lower case letters.

c

XbaI site is shown in lower case letters.

d

NotI site is shown in lower case letters.

The plasmid pUDK018 for deletion of the *smlt3723* gene was generated in a similar way. Using the primers KOsmlt3723-1 and KOsmlt3723-2, a 761 bp fragment homologous to the flanking region upstream of *smlt3723* was amplified. The PCR product was then digested with *Not*I and *Kpn*I for ligation into the *Not*I/*Kpn*I sites of pGPI-SceI-XCm. As a result, the plasmid pUDK017 was obtained. Finally, the deletion plasmid pUDK018 was derived from pUDK017 by amplification of a 660 bp fragment containing the flanking region downstream of *smlt3723* with primers KOsmlt3723-3 and KOsmlt3723-4, and cloning of the *Kpn*I/*Xba*I-digested PCR product into the *Kpn*I/*Xba*I sites of pUDK017.

The successful construction of all plasmids was verified by DNA sequence analysis of the inserts. The deletion plasmids were transferred to SMK279a by triparental mating as described previously ([@B9]), using *E. coli* DH5α carrying the plasmid pRK2013 as a helper strain, and *E. coli* SY327/pUDK012, SY327/pUDK015, and SY327/pUDK018 as the donor strains, respectively. Selection for SMK279a co-integrants was performed at 37°C on LB agar plates containing 60 μg/ml chloramphenicol and 5 μg/ml norfloxacin to counter-select against the *E. coli* helper and donor strains. Streaks of SMK279a exconjugants were subsequently sprayed with 0.45 M pyrocatechol to confirm integration of the deletion plasmids into the genomes of co-integrants. Due to the activity of the pyrocatechol 2,3-dioxygenase encoded by the *xylE* reporter gene of the deletion plasmids, a bright yellow color of the biomass was indicative of the presence of pUDK012, pUDK015, and pUDK018 in the genomes of the strains, respectively.

As a next step, the plasmid pDAI-SceI-SacB was introduced into the SMK279a co-integrants by triparental mating with DH5α/pRK2013 and DH5α/pDAI-SceI-SacB as helper and donor strains, respectively. Exconjugants were selected at 30°C on LB agar plates containing 50 μg/ml tetracycline and 5 μg/ml norfloxacin, followed by screening for excision of the deletion plasmids. Both the inability of pyrocatechol to turn the color of the exconjugants into bright yellow and sensitivity of the strains to 60 μg/ml chloramphenicol indicated the loss of the integrated plasmids. Finally, the plasmid pDAI-SceI-SacB was cured by sucrose counter-selection as described ([@B9]). As a result, the unmarked mutants SMK279aΔ*smlt1134*, SMK279aΔ*smlt2851*Δ*smlt2852* and SMK279aΔ*smlt3723* were obtained. The deleted regions of the mutant strains were verified by PCR and DNA sequence analysis.

The mutant strain SMK279aΔ*smlt0387* was generated according to [@B39] and [@B4].

RNA-seq and Data Analysis
-------------------------

To prepare the cell material for RNA-seq analyses, SMK279a was grown on LB agar plates with/without ampicillin (100 μg/ml). Two samples from each colony morphotype (small and big colonies) and two samples from uniform colonies were scrapped from agar plates after 48 h of growth at 37°C, pooled and immediately frozen in liquid nitrogen. About 10--15 mg of wet biomass were generally used for each biological replicate, 10 mg of cell material corresponded to an OD~600~ of 6.35. Additionally, for RNA extraction of liquid cultures, the strain SMK279a carrying the P*bla*~L2~::*rfp* reporter fusion was grown for 27 and 32 h with 100 μg/ml ampicillin. Total RNA was extracted using the hot-phenol method as described previously ([@B16]). The residual genomic DNA was removed from the total isolated RNA by DNase I treatment. All samples were adjusted to contain equal amounts of extracted RNAs. The cDNA libraries for sequencing were constructed by vertis Biotechnology AG, Germany as described by [@B74]. The transcripts were not fragmented. The cDNA libraries were sequenced using a HiSeq 2500 machine (Illumina) in single-read mode and running 100 cycles. To assure a high sequence quality, the Illumina reads in FASTQ format were trimmed with a cut-off phred score of 20 by the program fastq_quality_trimmer from FASTX toolkit version 0.0.13^[1](#fn01){ref-type="fn"}^. The alignment of reads, coverage calculation, gene wise read quantification and differential gene expression was performed with READemption ([@B30]) version 0.3.5 (doi: 10.5281/zenodo.13926), 'segemehl' ([@B40]) version 0.2.0 and DESeq2 ([@B52]) version 1.6.3. Visual inspection of the coverages was done using the Integrated Genome Browser (IGB; [@B62]). The reference sequence for SMK279a was retrieved from the NCBI database (accession no.: NC_010943.1). Genes with a fold-change of ≥2.0 and an adjusted *P*-value (corrected for multiple testing using the Benjamini--Hochberg procedure) ≤0.05 were considered as differentially expressed. The raw, de-multiplexed reads as well as coverage files have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus under the project ID: GSE71735. A shell script that covers the main RNA-Seq data processing steps was deposited at <https://zenodo.org/record/34153> (DOI:10.5281/zenodo.34153).

RT-qPCR
-------

Selected differentially regulated genes identified in SMK279a RNA-seq analyses were verified by RT-qPCR experiments as described previously ([@B48]). Gene-specific primers used for RT-qPCR are shown in **Table [3](#T3){ref-type="table"}**. Samples for RNA extraction were taken from colonies that had been grown for 48 h in the presence of ampicillin (100 μg/ml) and were obtained from three independent experiments. The SuperScript^®^ VILO^TM^ cDNA synthesis kit (Invitrogen^TM^, life technologies, TX, USA) was used to generate cDNA using 1.2 μg RNA. The expression values were normalized against *rpoD* and 16S rRNA.

###### 

Gene-specific primers used for RT-qPCR.

  Primer           Sequence \[5′-3′\]     Length of amplified product/gene
  ---------------- ---------------------- ----------------------------------
  qsmlt4165-Bfor   AAGGGCCTGGAACAGGGCTA   145 bp/*rpoD*^∗^
  qsmlt4165-Brev   CCACATCCGGCGCAACTTCA   
  q16S-Afor        AGAGTTTGATCCTGGCTCAG   240 bp/16S rRNA^∗^
  q16S-Arev        CTAATCCGACATCGGCTCAT   
  qsmlt2667-for    CGGTCACCTGCTGGACAACA   157 bp/*bla*~L1~
  qsmlt2667-rev    CACCGCCGTTTCTGCATTGG   
  qsmlt3722-Afor   CGTCGCCGATTCCTGCAGTT   144 bp/*bla*~L2~
  qsmlt3722-Arev   TTCCAGCGCGGCGAAATCAC   
  qsmlt3721-for    GAGCCATGAACTGATCTACC   196 bp/*smlt3721*
  qsmlt3721-rev    GAACAGGAACAGCGAGGAAA   
  qsmlt0018-for    CGGAACTGGAGTTCACTCTT   168 bp/*smlt0018*
  qsmlt0018-rev    TGATGTCCCAATCCGTTAGC   
  qsmlt0019-for    TAATACTAACGGCCCGACCT   205 bp/*smlt0019*
  qsmlt0019-rev    TCTTCCTGCACCTGAGTTCT   
  qsmlt1007-for    GAAGGCTTCACCAAGCTCAC   126 bp/*smlt1007*
  qsmlt1007-rev    GATGCCGGTCCAGATCGTAT   
                                          

∗

Genes used for normalization of gene expression.

Whole Genome Sequencing and Variant Detection
---------------------------------------------

Usually a single colony was transferred to fresh LB and cultured overnight to an OD~600~ of 1.0. Cells were pelleted, and the DNA was isolated with the AquaPure Genomic DNA Kit (Bio-Rad, Hercules, CA, USA). Libraries were generated following the Nextera XT DNA Library Preparation Kit (Illumina, San Diego, CA, USA) and sequenced on the MiSeq (2 × 310 bp) or NextSeq 500 (2 × 151 bp) platform (Illumina, San Diego, CA, USA). Respective FASTQ files were submitted to the EMBL EBI ENA short read archive^[2](#fn02){ref-type="fn"}^ (accession no.: ERP011093). Resulting reads were mapped to the SMK279a genome sequence (accession no.: NC_010943.1) with the alignment program SARUMAN ([@B15]). All isolates were sequenced with a minimum coverage of 50-fold. For variant detection in mapped reads, we employed customized Perl scripts using a minimum threshold of 10-fold coverage and a minimum allele frequency of 75% ([@B67]). Variant positions were then combined, supplementing the joint list with the respective information from the original mappings. Concatenating all SNP positions with a reliable base call (10-fold coverage and 75% allele frequency) in at least 95% of the isolates and no other SNP within a distance of 12 bp in the same strain yielded a sequence alignment for the construction of a maximum parsimony tree, which was built with the software BioNumerics version 7.5 (Applied Maths, Sint-Martens-Latem, Belgium).

Results
=======

Transient Colony Heterogeneity and Formation of Outer Membrane Vesicles in Response to Antibiotic Treatment
-----------------------------------------------------------------------------------------------------------

In the absence of antibiotics, the SMK279a wild-type strain forms cream-colored, round and uniform colonies with a diameter of approximately 1.75--2.0 mm after 24 h of growth on LB agar plates at 37°C. Addition of ampicillin (100 μg/ml) resulted in transient colony heterogeneity, with colonies differing in size and appearance (**Figure [1](#F1){ref-type="fig"}**) and could be observed as soon as they were visible on the plates. This was usually after 16--18 h of growth at 37°C for big colonies. Small colonies appeared between 24 and 33 h of growth. Colonies were grouped into three categories based on size and origin, i.e., small and big colonies in the presence of ampicillin (**Figure [1B](#F1){ref-type="fig"}**) and uniform colonies (**Figure [1A](#F1){ref-type="fig"}**) in the absence of ampicillin (**Table [4](#T4){ref-type="table"}**). Formation of different colony morphotypes was independent of the presence or absence of ampicillin in the pre-cultures. When grown in the presence of high concentrations of ampicillin (600 μg/ml), small and big colonies were observed (**Figure [1C](#F1){ref-type="fig"}**) and, furthermore, colonies slightly changed the color and appearance (**Figure [1D](#F1){ref-type="fig"}**). Among these colonies, some were pointed at the center while others appeared to have a flat colony surface with a wrinkled texture.

![**Phenotypic heterogeneity of SMK279a cells during growth on solid media.** **(A)** SMK279a forms round, uniform colonies when grown without ampicillin on LB agar plates for 48 h at 37°C. **(B)** Colony heterogeneity on LB agar supplemented with ampicillin showing small and big colonies after growth for 48 h at 37°C. **(C)** Small colonies (indicated by red dashed circle) and big colonies cultivated on agar plates containing high concentrations of ampicillin (600 μg/ml). **(D)** Colonies differ slightly in color when cultivated for 48 h on agar plates containing high concentrations of ampicillin (600 μg/ml).](fmicb-06-01373-g001){#F1}

###### 

SMK279a colony morphotypes observed after 48 h of growth on LB agar plates with and without ampicillin.

  Treatment       Concentration \[μg/ml\]   Colony morphotype   \% of all colonies   Colony size \[diameter, mm\]
  --------------- ------------------------- ------------------- -------------------- ------------------------------
  Ampicillin      100                       Small               80                   1.4 ± 0.26
  Ampicillin      100                       Big                 20                   3.2 ± 0.27
  No ampicillin   --                        Uniform             100                  3.0 ± 0.06
                                                                                     

When we streaked small colonies onto fresh plates without antibiotics, they formed uniform large colonies after overnight incubation, indicating the small colony morphotype was not caused by a genetic mutation. More importantly, small colonies formed both big and small colonies when recultivated in the presence of ampicillin. However, in the presence of ampicillin, cells from big colonies formed again a uniform colony at 24 and 48 h after transfer to fresh agar plates containing ampicillin. This reversible variation in colony morphology was also observed for other strains such as *S. maltophilia* CF148, an isolate from the respiratory tract of a cystic fibrosis patient, and *S. maltophilia* DSM-50170 isolated from the human oropharyngeal region (**Table [1](#T1){ref-type="table"}**).

Together with these findings, we observed that cells grown in the presence of ampicillin formed more frequently long bacterial chains (**Figure [2](#F2){ref-type="fig"}**). Furthermore, SMK279a cells from both colony morphotypes showed the formation of outer membrane vesicles (OMVs). However, this feature was much more pronounced in the presence of ampicillin (**Figures [2B--D](#F2){ref-type="fig"}**) in comparison to cells grown in the absence of the antibiotic that showed only very few or no vesicles (**Figure [2A](#F2){ref-type="fig"}**). Intriguingly, the size of the OMVs varied considerably, ranging from less than 100 nm up to 677 nm in diameter in some SMK279a cells, which was twice the size as those reported for other Gram-negative bacteria ([@B14]). Most likely, these vesicles are packed with *bla*~L1~ and *bla*~L2~ active enzymes ([@B24]).

![**Representative scanning electron micrographs (SEM) of SMK279a cells grown in the presence or absence of ampicillin at 37°C for 48 h on LB agar plates.** SEM images of SMK279a cells were recorded as previously published ([@B47]). **(A)** SEM image of cells obtained from colonies cultured in the absence of ampicillin. **(B)** SEM image of cells obtained from small colonies cultured in the presence of 100 μg/ml ampicillin. **(C)** SEM image of cells obtained from big colonies cultured in the presence of 100 μg/ml ampicillin. **(D)** SEM image of cells obtained from big colonies cultured in the presence of 300 μg/ml ampicillin. Cells from **(A--C)** predominantly formed long filamentous cells (indicated by letter F) and OMVs (indicated by arrows). In the presence of ampicillin, SMK279a cells became enlarged and formed OMVs with sizes up to 677 nm in diameter.](fmicb-06-01373-g002){#F2}

These initial data suggested that the observed colony morphotypes resulted either from gene expression differences at the cellular level within isogenic populations or from heterogeneous expression of resistance genes at a single cell level. Since colony morphotypes were reversible, they most likely were not a result of permanent mutations such as SNPs. To test this hypothesis, we sequenced DNA from 24 individual colonies with diverse morphotypes using NGS technology (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**). Overall, we analyzed the genomes of 13 small, 9 big, and 2 uniform colonies with an average 51.4-fold coverage. Compared with the published SMK279a genome sequence, we identified 2--15 SNPs per colony, up to seven deletions and four insertions within all colonies (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**). Most remarkably, none of these were identified within the known resistome of SMK279a, further supporting the notion that the colony morphotypes were not a primary result of genetic alterations.

A more detailed genome analysis identified SNPs or smaller deletions in 15 genes and ORFs, and none of these appeared to be linked to a gene that is essential for growth (**Supplementary Table [S2](#SM1){ref-type="supplementary-material"}**). Only one of the observed SNPs may be linked to β-lactam treatment, namely *smlt3885*, a gene which codes for a putative UDP-*N*-acetylmuramate:[L]{.smallcaps}-alanyl-gamma-[D]{.smallcaps}-glutamyl-meso-diaminopimelate ligase. This enzyme is most likely involved in recycling of cell wall precursors during bacterial cell wall synthesis but is not essential for growth ([@B57]). Two other regions in the SMK279a genome contained high densities of SNPs and indels. These loci are assigned to genes coding for the hypothetical protein Smlt1844B and a two-component regulatory system-sensor histidine kinase (Smlt3944). The *smlt1844B* and *smlt3944* genes carried non-synonymous mutations at seven or nine base positions, respectively (**Supplementary Table [S2](#SM1){ref-type="supplementary-material"}**). The product of *smlt3944* has a length of 880 amino acids and may be transcribed within an operon with the *smlt3943* gene coding for the phosphate-selective porin OprP (**Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}**). OprP is mainly expressed under conditions of phosphate starvation ([@B75]), and with the flanking gene *smlt3942* (encoding a C4-dicarboxylate transport protein), it is presumably under the regulatory effect of this sensor histidine kinase ([@B82]).

Based on these findings, we concluded that the observed colony heterogeneity is most likely due to reversible genetic switches causing differential gene expression at either a population and/or single cell level.

Differential Gene Expression in Small Versus Big Colonies
---------------------------------------------------------

The observed colony heterogeneity and differences in cell morphology prompted us to ask the question as to what extent the colony morphotypes would show different transcription profiles at a genome wide level. Therefore, we isolated total RNA from small, big and uniform colonies that were grown at 37°C for 48 h on LB plates. For this purpose, the different colonies were scraped off from the agar plates and pooled to obtain 10--15 mg of cell material for each colony type. We used colonies for RNA extraction as we expected that gene expression profile might reflect a different expression level given the different phenotypes. Given the above observation that the small colonies needed 24--33 h to appear on plates, a harvest at 48 h ensured us sufficient biomass and highly reproducible colony phenotypes for the RNA extraction.

After RNA extraction, cDNA libraries were constructed and sequenced using NGS. For each colony variant, we analyzed two independent biological replicates. Between 7.35 and 12.35 million reads were generated for the two biological replicates and aligned to the reference genome sequence of SMK279a (GenBank: NC_010943.1). The metadata of the samples and RNA-seq analyses are summarized in **Table [5](#T5){ref-type="table"}**.

###### 

Overall transcriptome metadata for the analyzed SMK279a colony morphotypes and liquid culture samples.

  Sample no.   Sample type      Sample time point   No. of reads generated (×10^6^)   No. of uniquely mapped reads (×10^6^)
  ------------ ---------------- ------------------- --------------------------------- ---------------------------------------
  1            Big colony       48 h                8.80                              0.69
  2            Big colony       48 h                9.88                              0.80
  3            Small colony     48 h                9.72                              0.63
  4            Small colony     48 h                12.35                             0.98
  5            Uniform colony   48 h                7.35                              0.38
  6            Uniform colony   48 h                9.60                              1.25
  7            Liquid culture   27 h                6.30                              0.39
  8            Liquid culture   27 h                6.90                              0.31
  9            Liquid culture   32 h                6.84                              0.46
  10           Liquid culture   32 h                6.85                              0.33
                                                                                      

For comparative analyses of RNA-seq data, we considered genes with a fold-change of ≥2.0, a Likelihood value ≥0.9 and an adjusted *P*-value of ≤0.05 as statistically significant and differentially expressed between the colony variants. The RNA-seq data unveiled that isogenic populations of SMK279a cells differentially regulate only a small number of genes between the colony morphotypes. Surprisingly, only 12 genes were significantly and differentially regulated between big and small colony variants (**Table [6](#T6){ref-type="table"}**, **Figure [3A](#F3){ref-type="fig"}**). Among the differentially expressed genes, *bla*~L1~ (*smlt2667*) and *bla*~L2~ (*smlt3722*) were 15.3- and 6.9-fold up-regulated in cells forming big colonies in comparison to those forming small colonies, respectively (**Table [6](#T6){ref-type="table"}**, **Figure [3B](#F3){ref-type="fig"}**). Upon β-lactam challenge, the transcriptional response in a small colony morphotype further included an altered expression level of genes involved in diverse cellular functions. The level of altered expression of these genes ranged from 2.0 to 3.6-fold, including down-regulation of eight of 14 genes, and up-regulation of six out of the 14 regulated genes (**Figure [3B](#F3){ref-type="fig"}**).

###### 

Differentially expressed genes for three colony morphotypes in SMK279a.

  Locus tag   Predicted function                                                   Fold-change big vs. small   Fold-change big vs. uniform   Fold-change small vs. uniform
  ----------- -------------------------------------------------------------------- --------------------------- ----------------------------- -------------------------------
  Smlt0018    Hypothetical protein                                                 +7.6                        +11.4                         --
  Smlt0019    Hypothetical protein                                                 +2.2                        +3.9                          --
  Smlt0706    Fimbria adhesin protein Smf-1                                        -2.3                        -2.0                          --
  Smlt0709    Fimbria adhesin protein                                              -2.0                        --                            --
  Smlt1735    tRNA delta(2)-isopentenyl pyrophosphate MiaA                         +2.4                        --                            --
  Smlt1766    Hypothetical protein                                                 +2.1                        --                            --
  Smlt2667    β-lactamase Bla~L1~                                                  +15.3                       +9.9                          --
  Smlt2668    Hypothetical protein                                                 +5.9                        +5.1                          --
  Smlt3721    Putative Na^+^/H^+^ antiporter AmpH                                  +3.6                        +3.5                          --
  Smlt3722    β-lactamase Bla~L2~                                                  +6.9                        +7.4                          --
  Smlt1844    Modification methylase                                               -2.0                        --                            --
  Smlt2601    Poly (beta-[D]{.smallcaps}-mannuronate) lyase                        -2.1                        --                            --
  Smlt0003    Hypothetical protein                                                 --                          --                            +2.1
  Smlt0028    DNA helicase II                                                      --                          --                            +2.0
  Smlt0044    RHS-repeat-containing protein                                        --                          --                            +2.0
  Smlt0201    Hypothetical protein                                                 --                          --                            +2.2
  Smlt0265    Acyl CoA dehydrogenase                                               --                          --                            -2.1
  Smlt0336    Hypothetical protein                                                 --                          --                            +2.3
  Smlt0353    Transposase                                                          --                                                        +2.0
  Smlt0596    Sensor histidine kinase RstB                                         --                          --                            -2.2
  Smlt0641    Undecaprenyl-phosphate 4-deoxy-4-formamido-l-arabinose transferase   --                          --                            +2.4
  Smlt1064    Hypothetical protein                                                 --                          --                            +2.8
  Smlt1391    Pseudogene                                                           --                          --                            +2.1
  Smlt1402    Methyl-accepting chemotaxis protein                                  --                          --                            +2.0
  Smlt1664    Hypothetical protein                                                 --                          --                            +2.6
  Smlt1760    Major facilitator super family transmembrane protein                 --                          \-                            -2.6
  Smlt2041    50S ribosomal protein L36 RpmJ                                       --                          --                            +2.0
  Smlt3041    Hypothetical protein                                                 --                          --                            +2.3
  Smlt3056    Transmembrane protein                                                --                          --                            +2.1
  Smlt3554    Anti-sigma factor RseA                                               --                          --                            -2.1
  Smlt3597    Dehydrogenase                                                        --                                                        -2.1
  Smlt4130    Two-component system response regulator AlgR                         --                          --                            -2.0
  Smlt4447A   Pseudogene                                                           --                          --                            +2.2
  Smlt4604    Endonuclease L-PSP family protein                                    --                          --                            +2.0
                                                                                                                                             

The table shows genes with a fold-change of ≥2.0, a Likelihood value ≥0.9 and an adjusted

P-

value of ≤0.05.

![**RNA-seq and RT-qPCR data analysis for different SMK279a colony morphotypes.** **(A)** Scatter plot of fold-change in transcription of genes among cells of big (*Y*-axis) and small (*X*-axis) colonies relative to untreated samples of uniform colonies grown in the absence of ampicillin on LB agar plates. A twofold change in the transcription of genes with adjusted *P*-value of ≤0.05 is considered as significantly, differentially regulated. Cells forming big colonies differentially regulated several genes mainly involved in degradation of antibiotics. The numbers in the plot indicate most strongly regulated genes: 1, *smlt0018*; 2, *smlt2667*; 3, *smlt3772*; 4, *smlt2668*; 5, *smlt0019*; 6, *smlt3721*; 7, *smlt1760*; and 7, *smlt0596*. **(B)** Differentially regulated genes in small colonies in comparison to big and uniform colonies. Down-regulation of *bla*~L1~ and *bla*~L2~ affected genes involved in regulation, metabolism, virulence, transport and genetic information processing/translation (for details see **Table [6](#T6){ref-type="table"}**). **(C)** Transcriptome profiles of *bla*~L2~ and the flanking genes *ampR* (*smlt3723*) and *ampH* (*smlt3721*) among the colony morphotypes. The *bla*~L2~ gene was 6.9-fold and 7.4-fold down-regulated in cells forming small colonies in comparison to big and uniform colonies, respectively. Transcriptome profile images of the leading strand (indicated in red) and the lagging strand (indicated in blue) were generated with the IGB software ([@B62]), merged and rearranged on the leading strand for a simplified visualization. **(D)** RT-qPCR analysis of genes, which were identified in the RNA-seq data set. Expression profiles of five different genes (*bla*~L2~; *ampH*; *bla*~L1~; *smlt0019*; *smlt0018*) were obtained from three independent experiments and analyzed based on the normalized gene expression \[2^-ΔΔ^*^C^*^(t)^ method\], using *rpo*D and 16S rRNA as internal reference genes.](fmicb-06-01373-g003){#F3}

Moreover, as summarized in **Table [6](#T6){ref-type="table"}**, 34 genes were identified to be differentially regulated in small colonies when compared to big and uniform colonies. Thus, four hypothetical proteins (Smlt0018, Smlt0019, Smlt1766, and Smlt2668), a putative Na+/H+ antiporter (Smlt3721, AmpH) and two fimbriae adhesin proteins (Smlt0706, Smf-1, and Smlt0709) are associated with the formation of the different colony morphotype. The fimbrial operon includes *smf-1* and *smlt0709* and is involved in haemagglutination, biofilm formation, and adherence to cultured mammalian cells ([@B21]). Notably, *smlt0018* and *smlt0019* most likely form an operon. Furthermore, although *ampH* is physically linked to *bla*~L2~ and the flanking *ampR* gene (*smlt3723*; **Figure [3C](#F3){ref-type="fig"}**), the function of *ampH* remains to be determined.

Expression analysis by RT-qPCR was used to confirm the RNA-seq data. We analyzed the expression profiles of five different genes (*bla*~L2~; *ampH*; *bla*~L1~; *smlt0019*; *smlt0018*) that were differentially transcribed between cells obtained from big and small colonies, including *rpo*D and 16S rRNA as internal reference genes. We analyzed expression data based on the normalized gene expression (2^-ΔΔ^*^C^*^T^ method), and the results confirmed the data obtained by RNA-seq (**Figure [3D](#F3){ref-type="fig"}**). The β-lactamase genes *bla*~L1~ and *bla*~L2~, as well as the putative Na^+^/H^+^ antiporter gene *ampH* were among the strongly upregulated genes in cells forming big colonies.

Since AmpR is the central regulator for the expression of β-lactamases, we analyzed the basal expression of *ampR* (*smlt3723*) in big vs. small colony variants. Therefore, we constructed an *ampR*-deletion mutant. The SMK279aΔ*smlt3723* deletion was verified by PCR and whole genome sequencing. Although the SMK279aΔ*smlt3723* mutant failed to grow on LB agar plates in the presence of 100 μg/ml ampicillin, it grew well in the absence of any added antibiotic. Therefore, this deletion mutant could not be used to analyze colony morphotypes in the presence of ampicillin.

Heterogeneous Expression of *bla*~L1~ and *bla*~L2~ in Single Cells
-------------------------------------------------------------------

In addition to the observed phenotypic heterogeneity with respect to colony morphologies and OMV formation, we speculated that β-lactamase expression might be subject to heterogeneous expression at a single cell level. To address this hypothesis, we constructed different reporter fusions in the broad host range vector pBBR1MCS-5 ([@B46]), using the promoter regions of *bla*~L1~ or *bla*~L2~ fused to the red (RFP), yellow (YFP), and cyan (CFP) fluorescent proteins (**Table [1](#T1){ref-type="table"}**). All obtained constructs were verified by sequencing and introduced into SMK279a by tri-parental mating using *E. coli* HB101 with pRK2013 as a helper plasmid ([@B28]). In the presence of ampicillin, SMK279a cells grew in long chains during the exponential growth phase rather than in individual rods or aggregates as observed during stationary growth phase. Furthermore, the ampicillin susceptibility of this bacterium was unchanged indicating that the native AmpR binding ligand remained intact and was not affected *in trans* by the P*bla*~L2~::*rfp* promoter construct (data not shown).

A detailed analysis of single cells by fluorescence microscopy indicated that *bla*~L1~ and *bla*~L2~ were heterogeneously expressed between individual bacterial cells (**Figure [4](#F4){ref-type="fig"}**). In an isogenic culture, we usually detected two stable subpopulations, i.e., individual cells in the *bla-*ON showing strong fluorescence and those in the *bla*-OFF mode that display no fluorescence. Noteworthy, individual cells within filaments (or aggregates) of exponentially growing cultures displayed a *bla*-ON mode, while adjacent cells were in a *bla*-OFF mode (**Figure [4C](#F4){ref-type="fig"}**). This phenomenon was observed in both cells expressing the *bla*~L1~ and the *bla*~L2~ gene fusion. Further tests in which the promoter of *bla*~L2~ was fused to a yellow and cyan fluorescent protein also confirmed heterogeneous expression of the β-lactamase within actively growing cells in the exponential phase (**Figures [4D,E](#F4){ref-type="fig"}**; **Supplementary Figure [S3](#SM1){ref-type="supplementary-material"}**).

![**Analysis of single cell fluorescence of P*bla*~L1~ and P*bla*~L2~ promoter gene fusions.** **(A)** Expression of the *bla*~L1~ promoter fused to *rfp* in SMK279a. Cells were grown at 30°C for 17 h under aerobic conditions (200 rpm) in LB medium containing 100 μg/ml ampicillin. Thereby, 2.0 ± 0.72% cells were in the *bla*-ON and 98.0 ± 0.72% cells were in the *bla*-OFF mode. **(B)** Expression of the *bla*~L2~ promoter fused to *rfp* in SMK279a grown under the same conditions as indicated in **(A)**. Here, 4.4 ± 0.69% of cells were in the *bla*-ON and 95.6 ± 0.69% cells were in the *bla*-OFF mode**. (C)** Phenotypic heterogeneity observed in cells (carrying the P*bla*~L2~::*rfp* fusion) forming long cell chains. Cells were grown overnight under aerobic conditions (120 rpm) in LB medium supplemented with 100 μg/ml ampicillin. **(D)** Phenotypic heterogeneity observed in cells carrying the P*bla*~L2~::*yfp* **(E)** and the P*bla*~L2~::*cfp* promoter gene fusion. **(F)** Control cells of SMK279a were grown under the same condition as described in (A) carrying a promoterless *rfp* reporter fusion (P~less~::*rfp*). Images were recorded with 63x/1.30 Oil M27 and 100x/1.30 Oil M27 lenses using a Zeiss Axio Imager 2 fluorescence microscope (Zeiss, Jena, Germany) and employing appropriate filters.](fmicb-06-01373-g004){#F4}

Additionally, we used SMK279a carrying the native promoter of the *ampR-bla*~L2~ intergenic region fused to *rfp* (P*bla*~L2~s::*rfp*; **Table [1](#T1){ref-type="table"}**). However, cells were in a *bla*~L2~-OFF mode indicating the lack of either the promoter recognition or the regulatory region that directs the expression of the reporter protein.

RNA-seq Indicates Few Significantly Differentially Regulated Genes in Homogenous Versus Heterogeneous *bla*~L2~-Expressing Cells
--------------------------------------------------------------------------------------------------------------------------------

Detailed statistical analyses of several hundred cells for each time point during growth in LB medium revealed that the majority (\>90%) of the cells were in the *bla*~L2~-OFF mode during the first 24 h of growth in 25 ml batch cultures on a shaker (200 rpm). After 32 h, however, the majority of cells expressed the red fluorescent reporter and, thus, was in the *bla*~L2~-ON mode (**Table [7](#T7){ref-type="table"}**). This response was independent of the presence of ampicillin. These observations prompted us to analyze the transcriptomes of cells that grew for 27 or 32 h in liquid cultures using RNA-seq. These two time points were selected because growth experiments and single cell counting indicated that less than 5% of all cells were in a *bla*~L2~-ON mode after 27 h, whereas more than 90% of all cells were in a *bla*~L2~-ON mode after 32 h. Data were analyzed as described above, and the transcriptomic metadata are summarized in **Table [5](#T5){ref-type="table"}**. Two biological replicates were analyzed for each time point. Interestingly, only three genes were differentially expressed between the two time points of 27 and 32 h: *smlt2851* and *smlt2852*, encoding a putative antibiotic resistance transporter and forming an operon, and a putative *comE* homolog (*smlt1134*). The *smlt2851* and *smlt2852* genes were 29- and 7.2-fold up-regulated, respectively, while *smlt1134* was 5.4-fold down-regulated at the 32-h sampling time point (**Figure [5A](#F5){ref-type="fig"}**). Additional RT-qPCR data supported the observation made for the *comE* homolog. RT-qPCR indicated a 1.74 ± 0.29-fold down-regulation in the transcription of the *smlt1134* gene among cells that were in the *bla*~L2~-ON mode vs. *bla*~L2~-OFF cells. For the *smlt2851* and *smlt2852* loci, RT-qPCR data did not confirm the RNA-seq data.

###### 

Effects of SMK279a P*bla*~L2~::*rfp* expression at a single cell level.

  Assayed SMK279a strain          Gene copy added       ^∗^% of cells showing the *bla*~L2~-ON mode after 32 h of growth
  ------------------------------- --------------------- ------------------------------------------------------------------
  SMK279a EM2                     --                    \>90%
  SMK279a EM8                     *comE* homolog        \<1%
  SMK279a EM9                     *smlt2851-smlt2852*   \>90%
  SMK279aΔ*smlt1134*              --                    \>90%
  SMK279aΔ*smlt2851*Δ*smlt2852*   --                    \>90%
  SMK279aΔ*smlt0387*              --                    \>90%
                                                        

∗

Data are mean values of three independent experiments and for each experiment we analyzed a minimum of 400 individual cells.

![**Expression of the c*omE* homolog (*smlt1134*) under its native promoter.** **(A)** Transcriptome profiles of *smlt1134* (black arrow) and flanking genes *smlt1133*; *smlt1135* (gray arrows) in an 'ON' state, 32 h (blue) and an 'OFF' state, 27 h (red). The *comE* homolog was found to be 5.4-fold down-regulated in the 'ON' state (32 h). Transcriptome profile images of the leading strand and the lagging strand \[generated with the IGB software ([@B62])\] were merged and rearranged on the leading strand for a simplified visualization. **(B)** Physical map and orientation of the *comE* homolog and both putative transporter genes in pBBR1MCS-5. The promoter regions were inserted upstream of P*bla*~L2~::*rfp*, resulting in pBBR1MCS-5::P*bla*~L2~::*rfp::smlt1134*; and pBBR1MCS-5::P*bla*~L2~::*rfp::smlt2851::smlt2852.* The recombinant plasmids were transferred to SMK279a cells and challenged with 100 μg/ml ampicillin. **(C)** Expression of the *comE* homolog in SMK279a under its native promoter P*~ComE~*. Cells were cultivated for 7 h in LB medium supplemented with 100 μg/ml ampicillin. Expression of *comE* clearly affects *bla*~L2~ heterogeneous expression resulting in non-fluorescing cells (*bla*~L2~-OFF mode), here less than 1% of cells were in the *bla*-ON mode. Right and left panels are a bright-field and a fluorescence microscopic image, respectively. **(D)** Expression of both putative transporter genes (*smlt2851*; *smlt2852*) in SMK279a under their native promoter P~2851/2852~. Expression of the transporter genes did not alter phenotypic heterogeneous expression of the *bla*~L2~ gene. Here, 5.5 ± 2.12% of the cells were in the *bla*-ON and 94.5 ± 2.12% cells were in the *bla*-OFF mode. Cells were cultured under the same condition as indicated in **(C)**. Right and left panels are a bright-field and a fluorescence microscopic image, respectively. Images **(C)** and **(D)** were recorded as described in **Figure [4](#F4){ref-type="fig"}**.](fmicb-06-01373-g005){#F5}

To analyze the impact of Smlt2851, Smlt2852, and Smlt1134 (ComE homolog) on phenotypic heterogeneous *bla*~L2~ expression, the genes were overexpressed in SMK279a. The respective operons and predicted promoter regions were PCR amplified and inserted upstream of P*bla*~L2~::*rfp* in pBBR1MCS-5, resulting in pBBR1MCS-5::P*bla*~L2~::*rfp::smlt1134*; and pBBR1MCS-5::P*bla*~L2~::*rfp::smlt2851::smlt2852* (**Figure [5B](#F5){ref-type="fig"}**). The recombinant plasmids were transferred to SMK279a cells and challenged with 100 μg/ml ampicillin. Only the overexpression of the *comE* homolog in SMK279a resulted in an altered transcriptomic profile with respect to phenotypic heterogeneity at a single cell level (**Figure [5C](#F5){ref-type="fig"}**; **Table [7](#T7){ref-type="table"}**). The expression of extra copies of the *comE* homolog in SMK279a reduced the frequency of *bla*~L2~-ON cells to 1 % or lower after 32 h of growth. The overexpression of both putative transporter genes (*smlt2851*; *smlt2852*) under their native promoter did not alter phenotypic heterogeneous expression of the *bla*~L2~ gene (**Figure [5D](#F5){ref-type="fig"}**). In corresponding control sets, usually \>90% of all cells were in a *bla*~L2~-ON mode (**Table [7](#T7){ref-type="table"}**).

Furthermore, we constructed deletion mutants of both loci, *smlt1134* (*comE* homolog) and *smlt2851*--*smlt2852* (**Supplementary Figure [S4](#SM1){ref-type="supplementary-material"}**). However, phenotypic heterogeneous gene expression of the *bla*~L2~ reporter fusion was not altered in the background of any of these deletion mutants, suggesting that the lack of expression is not linked to heterogeneous expression. Furthermore, the use of a deletion mutant strain with a mutation in the *smlt0387* gene (*ax21* homolog) did not show phenotypic heterogeneity (**Table [7](#T7){ref-type="table"}**). The Ax21 peptide was suggested to act as a cell--cell signal to regulate a diverse range of functions, including virulence, in *Stenotrophomonas* ([@B56]). Taken together, the data indicate that the ComE homolog appears to be involved in the regulation of phenotypic heterogeneity of *bla*~L2~ gene expression in *S. maltophilia*.

Disussion
=========

*Stenotrophomonas maltophilia* encodes in its genome for two β-lactamases, L1 and L2. Expression of both β-lactamases is mainly controlled through the function of the master regulator AmpR in the presence of β-lactam antibiotics. The activity of AmpR is modulated via its activator (anhydro-MurNAc-oligopeptide) and repressor (UDP-MurNAc-oligopeptide) ligands ([@B25]; [@B42]; [@B13]). Here we provide the first evidence, that beside these well-known regulatory elements, phenotypic heterogeneity plays a crucial role in β-lactamase gene expression and has profound effects on colony morphotypes. Non-genetically determined phenotypic heterogeneity has been observed in many bacteria as extensively reviewed ([@B1]; [@B33]). Well-studied systems with respect to phenotypic heterogeneity include the phenomenon of persister cells, activation of autoinducer synthase genes, flagella biosynthesis, and others ([@B8]; [@B23]; [@B60]; [@B32]; [@B80]). The term 'phenotypic heterogeneity' thereby describes the more general phenomenon of heterogeneous behavior within isogenic cultures and is often linked with the term 'bet-hedging', which describes the evolutionary strategy for phenotypic heterogeneity.

The data presented in this study imply that SMK279a forms phenotypic heterogeneous subpopulations with respect to the expression of both β-lactamase genes. Two lines of evidence support this hypothesis. Firstly, cells from small and big colony variants differ mainly in the expression of 12 genes, with both β-lactamase genes *bla*~L1~ and the *bla*~L2~ being among the strongest differentially regulated genes between the two different colony morphotypes (**Table [6](#T6){ref-type="table"}**). Several distinct expression patterns were stable enough to allow differentiation into different colony morphotypes. SEM analyses further revealed that many cells rather grew as long cell chains and produced OMVs in response to β-lactam treatment (**Figures [2B,C](#F2){ref-type="fig"}**). This phenomenon, however, was only observed in part of the populations. A second line of evidence resulted from data obtained with promoter fusions of the *bla*~L1~ and *bla*~L2~ genes. High levels of heterogeneous β-lactamase expression were observed in liquid cultures. Although, the overall number of cells that were in an ON mode varied between the different promoter fusions, they all shared the common feature of heterogeneous *bla*~L1~ and *bla*~L2~ expression (**Figures [4A--E](#F4){ref-type="fig"}**). Indeed, a weak and constitutive expression of the *bla*~L1~ and *bla*~L2~ genes was present in untreated cells that were grown in an environment free of stressful antibiotic challenges.

Furthermore, genome-wide sequence analysis of 24 colony variants identified a significant number of SNPs. The majority of SNPs were affiliated with genes encoding the two-component regulatory system-sensor histidine kinase Smlt3944 and the hypothetical protein Smlt1844B (**Supplementary Tables [S2](#SM1){ref-type="supplementary-material"}** and **[S3](#SM1){ref-type="supplementary-material"}**). Remarkably, none of the SNPs were observed in any of hitherto known genes that are part of the SMK279a resistome. These data imply that the colony morphotypes were indeed a result of heterogeneous behavior within a syngeneic bacterial population mainly involving genetic switches during alternations from one state to another. Furthermore, this phenotypic diversity is reversible but not based on β-lactam induced mutagenesis, since mutagenesis in bacteria has been shown to be only caused by sub-inhibitory concentration of β-lactams ([@B34]). Our study also revealed that the phenotypic heterogeneity described inhere differs from previously described small colony variants (SCVs) isolated for many pathogens, including *S. maltophilia* ([@B64]; [@B7]). SCVs represent a subpuplation of slow-growing bacteria with growth characteristics and morphotypes distinct from those of the wild-type counterparts. Our data further indicate that ComE is part of a network involved in the regulation of phenotypic heterogeneity in SMK279a. Consequently, overexpression of the *comE* homolog resulted in a decreased heterogeneity of *bla*~L2~ expression. The *comE* gene codes for a DNA-binding protein that has been identified previously as part of a regulatory cascade responsible for bacterial heterogeneity in the Gram-positive bacterium *Streptococcus pneumoniae* ([@B43]). It is noteworthy that ComE contains a helix-hairpin-helix (HhH) motif, which is mainly involved in non-sequence-specific DNA-binding ([@B72]). Thereby, post-transcriptional regulation of the *comE* gene involves in part the RNA-binding protein (Hfq) that regulates a wide variety of cellular responses via interacting with small RNAs (sRNAs) and mRNAs ([@B68]), indicating the complex network for *comE* regulation and its diverse roles in cells. Within this framework, *comE* might also be involved in regulating phenotypic heterogeneity with respect to the *bla*~L2~ gene expression (**Figure [5C](#F5){ref-type="fig"}**, **Table [7](#T7){ref-type="table"}**). Finally, it is important to consider that the underlying mechanism for modulating phenotypic heterogeneity is complex, involving in some cases several genes from the regulatory circuit ([@B59]).

In summary, phenotypic heterogeneity affects β-lactamase expression in SMK279a. We speculate that phenotypic heterogeneity in SMK279a cells provides a selective advantage in natural environments and during the infection of human epithelia to respond against antimicrobial effectors. This adaptation is probably also relevant during acute and chronic human infections associated with *S. maltophilia* and effectiveness of antibiotic treatment. Future work will identify the underlying molecular switches involved in triggering phenotypic heterogeneity in *S. maltophilia*.

Author Contributions
====================

EA is the contributing author. EA, DK and WRS wrote and edited the manuscript. UM provided mutants and edited the manuscript. TK and SN provided the SNP analyses; KF provided the RNA-seq data; IK-M, CS, US also contributed to this research and manuscript.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

EA was supported by a grant from the German Academic Exchange program (DAAD). Part of this work were funded through the DFG grant STR451/7-1 within the priority program SPP1617, by the EU FP7 Patho-Ngen-Trace (FP7- 278864-2) project, and by in house funding of the Research Center Borstel. We thank Dörte Grella and Manuel Hein (Research Center Borstel) for technical assistance as well as Julia Zallet and Tanja Ubben for their help with library preparation and sequencing. The authors are grateful to Miguel A. Valvano (Center for Infection and Immunity, Queen's University, Belfast, UK) for providing the pGPI-SceI/pDAI-SceI-SacB system.

<http://hannonlab.cshl.edu/fastx_toolkit/>

<http://www.ebi.ac.uk/ena>

Supplementary Material
======================

The Supplementary Material for this article can be found online at: <http://journal.frontiersin.org/article/10.3389/fmicb.2015.01373>

###### 

Click here for additional data file.

[^1]: Edited by: *Akos T. Kovacs, Friedrich Schiller University Jena, Germany*

[^2]: Reviewed by: *Stephen Peter Kidd, University of Adelaide, Australia; Wolfgang Eisenreich, Technische Universität München, Germany; Romain Briandet, Institut National de la Recherche Agronomique, France*

[^3]: This article was submitted to Microbial Physiology and Metabolism, a section of the journal Frontiers in Microbiology
